Analysis suggests risk of suicidal ideation associated with semaglutide
Pubblicazione: (2024)

Study finds semaglutide not associated with higher risk of suicidality
Pubblicazione: (2024)

The demise of metformin and the rise of the GLP‐1 agonists
di: Lawrence H. Price
Pubblicazione: (2026)

Postpartum hormonal contraceptives increase risk of depression
Pubblicazione: (2025)

Benzodiazepine use not associated with increased risk of dementia
Pubblicazione: (2024)

Antidepressants for bipolar depression do not increase risk of mania
Pubblicazione: (2024)

Some anti‐psychotics associated with increased risk of pneumonia
Pubblicazione: (2024)

Use of SSRIs with anticoagulants can increase risk of bleeding
Pubblicazione: (2024)

FDA requests removal of suicide warnings from two GLP‐1 labels
Pubblicazione: (2026)

Comprehensive study of GLP‐1 effects suggests neuropsychiatric benefits
Pubblicazione: (2025)

Update: Reports of suicidality in patients taking diabetes/obesity medicines
Pubblicazione: (2024)

ED visit for psychedelic use confers increased risk of psychosis
Pubblicazione: (2025)

Combination of SSRI and methylphenidate does not increase adverse event risk
Pubblicazione: (2024)

High‐dose amphetamines associated with increased risk of psychosis, mania
Pubblicazione: (2024)

Review finds GLP‐1s have favorable psychiatric safety profile
Pubblicazione: (2025)

Antipsychotics for delirium in ICU did not result in QTc interval prolongation
Pubblicazione: (2024)

Discontinuation of benzodiazepines after long‐term use increases mortality risk
Pubblicazione: (2024)

DBT more efficacious than SSRI in reducing suicidality in borderline personality disorder
Pubblicazione: (2026)

Heatwaves exacerbate risk of illnesses in patients with mental health conditions
Pubblicazione: (2025)

Anti‐psychotic use in dementia patients linked to risk of numerous illnesses
Pubblicazione: (2024)

Use of ADHD medications increased sharply during pandemic
Pubblicazione: (2024)

Researchers recommend training ED physicians on suicide risks in children and teens
di: Alison Knopf
Pubblicazione: (2024)

Psychedelics and psychosis: Quantifying the risk
di: Lawrence H. Price
Pubblicazione: (2025)

Antimicrobial exposure and risk of depression
di: Y. W. Francis Lam
Pubblicazione: (2025)

Cannabis‐related hospitalization linked to risk of dementia
Pubblicazione: (2025)

LAI added to clozapine reduces risk of hospitalization
Pubblicazione: (2024)

No protective effect of omega‐3s for youths at risk of psychosis
Pubblicazione: (2025)

Patients with COPD show risk of worsening from gabapentinoids
Pubblicazione: (2024)

Higher autism risk with valproate than topiramate, lamotrigine
Pubblicazione: (2024)

Antipsychotic classes differ in risk of cardio‐cerebrovascular mortality
Pubblicazione: (2024)

Pimavanserin reduced risk of relapse to psychosis in Parkinson's dementia
Pubblicazione: (2024)

Phenotypes of CYP2D6 do not predict adverse events in patients with depression
Pubblicazione: (2024)

First‐line antidepressants decrease fall risk in elderly with depression
Pubblicazione: (2024)

Meta‐analysis suggests risk of psychosis from stimulant treatment for ADHD
Pubblicazione: (2025)

Study finds gabapentinoid treatment does not elevate risk of self‐harm
Pubblicazione: (2025)

Small differences in weight gain risk among commonly used antidepressants
Pubblicazione: (2024)